Products

Compliance Commitment

Integrity Commitment and Compliance Program

Code of Business Ethics

Integrity Commitment Pledge

Kit Description

Photo Guide

Schematic

FAQ

Back to Product List

Catalog #	Kit Name
IF0100G	Rickettsia IFA IgG

	Indirect immunofluorescent antibody (IFA) test for the detection and semi-quantitation of human serum IgG antibodies to Rickettsia rickettsii, the etiologic agent of Rocky Mountain spotted fever, and to Rickettsia typhi, the etiologic agent of murine typhus. Each kit contains ten 8-well slides with individual spots of R. typhi and R. rickettsii in each well, yolk sac diluent, IgG conjugate, and positive and negative controls.

	Package Inserts

Rickettsia IFA (IF0100G and IF0100M)

Slide 1	Slide 2
Negative	Positive
	Rickettsia Spotted Fever	Rickettsia Typhus Fever

Rickettsia IFA Slide Schematic

Rickettsia as Viewed through Microscope

Frequently Asked Questions (FAQ)

Q: How are the antigens arranged on the slide?

A: Please see the slide schematic shown above for this information.

Q: Why is the positive control for this IFA kit barely positive at the screening dilution?

A: The positive controls are bottled at the screening dilution and can be titered for an endpoint from this dilution. The control should be used in the first well without further dilution.

Q: What antigens do you use for Rickettsia testing?

A: We have IFA slides with both Rickettsia rickettsii, representing the spotted fever group, and Rickettsia typhi representing the typhus fever group.

Back to Product List

First FDA Clearance of a 2009 H1N1 Test Given to Focus Diagnostics

FDA Issues Another Emergency Use Authorization for Commercial H1N1 Flu Test to Quest Diagnostics� Focus Diagnostics

Focus Diagnostics provides the first commercial test for detecting the 2009 H1N1 influenza virus that the FDA has authorized for emergency use.